• FDA OKs Odevixibat for Pruritus Associated With Rare Liver Disease

    3 days ago - By Medscape

    Odevixibat is the first drug approved for the treatment of severe itching in children as young as 3 months with progressive familial intrahepatic cholestasis.
    FDA Approvals
    Read more ...

     

  • FDA OKs First Drug for Symptoms of Rare Liver Disease in Kids

    FDA OKs First Drug for Symptoms of Rare Liver Disease in Kids

    3 days ago - By MedPageToday

    The FDA approved odevixibat for treating young children with intense itching caused by progressive familial intrahepatic cholestasis , manufacturer Albireo Pharma announced on Tuesday.
    Odevixibat becomes the first...
    Read more ...